![](https://webarchive.library.unt.edu/eot2008/20090509104719im_/http://www.cancer.gov/images/spacer.gif) |
|
Supportive Care Trial Results
11. For Cancer-Related Appetite Loss, Cannabis Is No Better than Placebo (Posted: 08/09/2006) - THC taken alone, or combined with another marijuana compound that reduces THC's psychoactive effects, is no more effective than a placebo at enhancing appetite for advanced cancer patients, according to the July 20, 2006, issue of the Journal of Clinical Oncology.
![](https://webarchive.library.unt.edu/eot2008/20090509104719im_/http://www.cancer.gov/images/spacer.gif)
12. Nonhormonal Therapies Have Little Effect on Hot Flashes (Posted: 05/10/2006) - A review of clinical trials investigating nonhormonal treatments for hot flashes, a symptom associated with some cancer treatments, found that they offer only modest benefits, according to the May 3, 2006, issue of the Journal of the American Medical Association.
![](https://webarchive.library.unt.edu/eot2008/20090509104719im_/http://www.cancer.gov/images/spacer.gif)
13. Gabapentin (Neurontin®) Reduces Hot Flashes In Breast Cancer Patients (Posted: 09/19/2005) - The drug gabapentin (Neurontin®) effectively reduced the intensity and duration of hot flashes in a clinical trial of more than 400 breast cancer patients, according to the Sept., 3, 2005, issue of the Lancet.
![](https://webarchive.library.unt.edu/eot2008/20090509104719im_/http://www.cancer.gov/images/spacer.gif)
14. Surgery Helps Relieve Spinal Cord Compression Caused by Metastatic Cancer (Posted: 06/02/2003, Updated: 08/23/2005) - Surgery followed by radiation is more effective than radiation alone in treating spinal cord compression caused by metastatic cancer.
![](https://webarchive.library.unt.edu/eot2008/20090509104719im_/http://www.cancer.gov/images/spacer.gif)
15. Frozen Glove Reduces Skin and Nail Damage from Docetaxel Chemotherapy (Posted: 08/01/2005) - Patients who wore an experimental "frozen glove" to keep their hands very cold during intravenous chemotherapy with docetaxel (Taxotere®) had much less subsequent damage to the nails and skin of their hands, according to a study published in the July 1, 2005, issue of the Journal of Clinical Oncology.
< Previous 1 2 3 4 5 6 Next > |
|
![](https://webarchive.library.unt.edu/eot2008/20090509104719im_/http://www.cancer.gov/images/spacer.gif) |